Fact CheckerSign in

NCT05339893CompletedPhase 2

Trans Auricular Vagus Nerve Stimulation (taVNS) and Robotic Training for Paralyzed Arm After Stroke

Evaluating the Use of Trans Auricular Vagus Nerve Stimulation (taVNS) and Robotic Training to Improve Upper Limb Motor Recovery After Stroke

Source: ClinicalTrials.gov · Last updated 6 Oct 2026

Brief summary (registry, in English)

To determine whether treatment with transauricular vagus nerve stimulation (taVNS) during the training of an affected upper limb of a patient with chronic stroke on a robotic motor task alters the motor impairment.

Status (registry)
Completed
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
40 (actual)
First submitted
29 Mar 2022
Start date
12 Sept 2022
Primary completion date
13 Apr 2026
Lead sponsor
Northwell Health
Diseases
Stroke
NCT number
NCT05339893

What you commit to

  • Study type: Interventional · Phase 2
  • Participants enrolled: 40
  • From 12 Sept 2022 to the primary completion date, 13 Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior injury to the vagus nerve

Other illness

  • Significant arrhythmias, including but not limited to, atrial fibrillation, atrial flutter, sick sinus syndrome, and A-V blocks (enrollment to be determined by PI review)
  • Presence of an electrically, magnetically or mechanically activated implant (including cardiac pacemaker), an intracerebral vascular clip, or any other electrically sensitive support system; Loop recorders will be reviewed on a case by case basis by PI and the treating Cardiologist to make a determination

Other

  • Recent fever or upper respiratory symptoms.
  • Botox treatment within 3 months of enrollment
  • Fixed contraction deformity in the affected limb
  • Complete and total flaccid paralysis of all shoulder and elbow motor performance
  • Severe dysphagia
  • Introduction of any new rehabilitation interventions during study
  • Individuals with scar tissue, broken skin, or irremovable metal piercings that may interfere with the stimulation or the stimulation device
  • Highly conductive metal in any part of the body, including metal injury to the eye; this will be reviewed on a case by case basis for PI to make a determination
  • Pregnant or plan on becoming pregnant or breastfeeding during the study period

Who the study is looking for

  • In receipt of full vaccination status and no recent upper respiratory symptoms and no loss of taste or olfaction.
  • Individuals between 18 and 85 years of age
  • First single focal unilateral supratentorial ischemic stroke with diagnosis verified by brain imaging (MRI or CT scans) that occurred at least 6 months prior
  • Cognitive function sufficient to understand the experiments and follow instructions (per interview with Speech Pathologist or PI)
  • Fugl-Meyer assessment 12 to 44 out of 66 (neither hemiplegic nor fully recovered motor function in the muscles of the shoulder, elbow, and wrist).

Age in the registry: 18 years to 85 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Feinstein Institutes at Northwell Health
Coordinator of this site? Confirm its status
ManhassetUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.